Manager, Competitive Intelligence @ Arsenal Biosciences, Inc. (January 2025 - August 2026)
Head of Target Biology and and Senior Scientist II @ Arsenal Biosciences, Inc. (September 2024 - August 2026)
Senior Scientist @ Arsenal Biosciences, Inc. (September 2022 - August 2024)
Scientist @ Arsenal Biosciences, Inc. (September 2020 - August 2022)
PhD Candidate @ (January 2016 - May 2020)
Stanley Zhou Education
University of Toronto
Doctor of Philosophy - PhD (Cancer Biology)
Harvard Business School Online
CORe Program (Business)
University of Toronto - Victoria University
Hon. Bachelor of Science (Hon. BSc) (Cell/Cellular and Molecular Biology, Health and Disease)
Stanley Zhou Skills
Research
Cancer Biology
Cell Biology
Cancer Genomics
Tissue Culture
ChIP
Western Blotting
Regenerative Medicine
Immunohistochemistry
Animal Surgery
Microtome
Histology
Microsoft Office
Microsoft Excel
Microsoft Word
Public Speaking
PowerPoint
Management
Strategic Planning
Leadership
Accountability
Building Trust
Business Development
Business Risk
Business Strategy
Cancer Research
Chromatin Immunoprecipitation
Clinical Research
Clinical Trial Analysis
Communication
Competitive Intelligence
Diversity & Inclusion
Due Diligence
Epigenomics
Equity Research
Financial Statements
Functional Genomics
Generative AI
High Performer
Market Analysis
Microsoft PowerPoint
Oncology
Organizational Leadership
PCR
Personal Development
Relationship Building
Resiliency
Translational Research
Ucsc Genome Browser
Stanley Zhou Summary
Stanley Zhou, based in California, United States, is currently a Director, Translational Sciences at Valius Sciences. Stanley Zhou brings experience from previous roles at Arsenal Biosciences, Inc.. Stanley Zhou holds a Doctor of Philosophy - PhD in Cancer Biology @ University of Toronto. With a robust skill set that includes Research, Cancer Biology, Cell Biology, Cancer Genomics, Tissue Culture and more. Stanley Zhou has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Stanley Zhou?
Find contact details for 700 million professionals.